
Pharmaceutical Commerce - November 2019


DEA’s manufacturer and distributor data-collection requirements are changing

Getting away from the traditional product-centric management structure is not easy; here’s how to do it

Key priorities: cleansed data and consolidated databases

Dealing with pharma’s commercial data deluge

Sample management is just one of many focus areas for sales operations

Collaborations with AmerisourceBergen and CVS Pharmacy expand UPS’ commercial footprint

Properly serialized product levels have tripled in the past year

Merck’s Ervebo vaccine gets CHMP positive opinion

New player in hub services expands its call center operations

‘Global privacy regulation’ and ‘digital health’ bracket the 10 influences going into 2020
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring
2
The Key to Connecting with Patients: Pharma's Market Access Transformation
3
Alcami Brings Third Sterile Fill-Finish Line Online. Expanding Clinical-to-Commercial Capacity
4
Trade & Channel Strategies 2025: Inside Pharma’s Turning Point
5